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result of a point mutation (T to C) at nucleotide position 8851 of the
mitochondrial DNA (mtDNA). This mutation changes a highly
conserved tryptophane residue to arginine at amino acid position
109 of the subunit a of mitochondrial F1FO-ATP synthase, a complex
which provides most of the cellular ATP in humans. Nothing is
known on the consequences of the T8851C mutation on the
mitochondrial ATP synthase. To gain insight into the primary
pathogenic mechanisms induced by T8851C, we have investigated
the consequences of this mutation on the ATP synthase of yeast
where the protein homologous to subunit a (referred to as Atp6p) is
also encoded by the mtDNA. The modified yeast exhibited a very
slow growth phenotype on non-fermentable carbon sources, both at
28 °C (the optimal temperature for growing yeast) and at 36 °C. In
vitro, mitochondria from T8851C yeast grown at 28 °C showed a 60%
deficit in ATP production, while those prepared from the mutant
grown at 36 °C had an ATP synthesis activity below 5% that of the
wild type. The mutated F1FO complex was correctly assembled, at
both temperatures, and had a very poor ATPase activity (10% that
of the wild type), both in mitochondria and after purification.
Electron microscopy revealed that many of the mitochondrial
matrices in T8851C yeast grown at 36 °C exhibited septae made of
apposed inner mitochondrial membranes. Another anomaly was an
increased mitophagic activity, presumably in response to the
T8851C-induced damaging of mitochondria. Thus, in addition to a
bioenergetic deficit, alterations in mitochondrial dynamics and
homeostasis may also participate in the pathogenic mechanism
induced by T8851C.
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Mitochondrial disease is an energy metabolic disorder with
various organ involvements. Iron is widely known to be one of the
most important nutriments required for normal brain development
and several essential metabolic functions. We retrospectively studied
the laboratory data on iron deficiency (ID) in 69 children with
mitochondrial respiratory chain complex (MRC) defects by biochem-
ical enzyme assay using muscle tissue. We analyzed the differences
between groups of mitochondrial disease based on the presence of ID.
ID has higher prevalence in children with mitochondrial disease than
in the normal population. There were 6 (9%) patients with low
hemoglobin, 12 (17%) with low serum ferritin, and 22 (32%) with low
transferrin saturation levels among children with MRC defects. In
comparisons between the ID and the non-ID group of MRC-defect
patients, the frequency of MRC I defect was significantly higher in the
ID group while that of MRC IV defect was higher in the non-ID group.
Abnormal brain magnetic resonance imaging (MRI) findings were
more frequently detected in the ID group. The incidence of failure to
thrive and gastrointestinal symptoms were significantly higher in the
ID group. Early diagnosis and proper treatment of ID are recom-
mended. Especially in cases with risk factors such as failure to thrive
or gastrointestinal manifestation, active evaluation of ID should be
encouraged.
doi:10.1016/j.bbabio.2010.04.170
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Cytochrome c oxidase (COX, CIV) is one of the complexes of the
OXPHOS system located in the inner mitochondrial membrane and
catalyzing the last step of electron's transfer from cytochrome c to
molecular oxygen. It is composed of 13 subunits encoded by
mitochondrial and nuclear DNA. A correct assembly and function of
COX require a substantial number of the nuclear, ancillary proteins,
including SCO2, which is involved in the transport and incorporation
of the cooper ions to the CuA enzymatic site on COXII subunit. Human
SCO2 gene is located on the chromosome 22q13, and contains two
exons. Only the 801 bp fragment of exon 2 undergoes translation into
266 amino acid protein. Mutations in the SCO2 gene lead to serious
damage of the protein resulting in severe COX deficiency observed
mainly in muscle, heart and brain. The common substitution,
g.1541G>A (p.E140K) was identified at least on one allele in all so
far reported patients with COX deficiency. In the group of 23 Polish
patients, the common substitution was found on 84% of the studied
alleles. The clinical features of the disease associated with SCO2
deficiency include early onset, fatal hypertrophic cardiomyopathy
with respiratory insufficiency, encephalopathy, hypotonia and meta-
bolic acidosis. The aim of this study was to characterize the molecular
background of the disease in three patients from two unrelated
families with clinically and biochemically recognized cytochrome c
oxidase deficiency. Here we present patients with the same genotype,
comprising the common mutation, g.1541G>A and a new, not
described in the literature, molecular variant g.1653T>C. The new
variant affects the highly conserved methionine at 177 position of the
SCO2 protein (p.M177T) and was not found on 600 control alleles.
Additionally, g.1653T>C substitution was predicted by SIFT BLink
programme as a pathogenic mutation. Our findings indicate that the
compound heterozygous genotype, p.M177T/p.E140K, is responsible
for clinical manifestation of destroyed SCO2 protein.
The study was partly supported by the CMHI project no. S11/2009
and Polish Ministry of Science Project no. PB 0890/P05/2005/29.
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Leigh syndrome is most frequently caused by mutations of SURF1
gene, which encodes cytochrome c oxidase (COX) specific assembly
factor. Our previous studies suggested that fibroblasts from patients
harbouring SURF1 mutations accumulate incomplete forms of COX
lacking several small nuclear-encoded subunits with decreased H+/e
stoichiometry. In experiments aimed at detailed characterization of the
mitochondrial energetics, we observed 30–50% decreased respiratory
capacity available for ATP synthesis (RCRP). When using COX-specific
substrates ascorbate + TMPD, the RCRP was 7-fold lower than in
controls, suggestive of deficient proton pumping of COX in patient
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fibroblasts. The impairment of proton-translocation activity of COX was
directly confirmed by mitochondrial membrane potential measure-
ments using TPP+ electrode. While proton pumping at complexes I and
III in patient fibroblasts was similar to controls, ascorbate + TMPD
substrates were unable to support generation of proton gradient.
Consequently, mitochondrial membrane potential as estimated by JC-1
staining was lower in intact patient fibroblasts, leading to extremely
decreased rates of mitochondrial ATP production to 25% of control
values. Such drop in energy provision ultimately resulted in two-fold
decrease of ATP/ADP ratio in patient cells grown in galactose medium,
when most of ATP must be synthesized by mitochondria. In contrast to
profound impairment of mitochondrial energetics, no changes in the
production of reactive oxygen species (ROS) or antioxidant defences
could be found in patient fibroblasts. This is perhaps due to decreased
mitochondrial membrane potential, which may serve as a paradoxical
ROS-preventing mechanism. We conclude that unlike to mitochondrial
disorders caused by dysfunction of ATPase or complex I, the pathogenic
mechanism of COX deficiencies seems to have only single component—
impaired mitochondrial energy provision.
This work was supported by grants fromGrant Agency of the Czech
Republic (303/07/781) and Ministry of Education (1M6837805002,
AV0Z 50110509) of the Czech Republic.
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Genetic defects in enzymes of oxidative phosphorylation cause a
broad spectrum of mitochondrial encephalomyopathies. Apart from
diminished ATP production per se, elevated oxidative stress is
implicated in pathogenic mechanism of mitochondrial diseases. In our
work we used fibroblasts from patients with isolated deficiency of ATP
synthase caused bymutation inTMEM70gene to study consequences on
mitochondrial function, in vivoROSproduction and levels of cellular ROS
scavengers.With the aim to elucidate how the lowATP synthase content
affectsmitochondrial energy provision,we have investigated fibroblasts
from patients with ATP synthase content decreased to <30% of the
control. Measurements of cellular respiration showed insufficient ATP
synthase capacity for basal respiration andmitochondrial ATP synthesis
was decreased to 26–33%.Cytofluorometric analysis using TMRM
revealed increased mitochondrial membrane potential (Δψm) at state
3-ADP in patient cells. Consequently, viability of patient fibroblasts was
more sensitive to ATP synthase inhibitors oligomycin or aurovertin.
Analysis of ROS production by CM-H2DCFDA demonstrated increase in
ROS production and decrease of MnSOD activity in two patients, while
level of main cellular ROS scavenger glutathione was only mildly
decreased compared to control. In the third patient ROS productionwas
not changed but MnSOD activity was dramatically increased and
glutathione level decreased. Our results indicate two-component
pathological mechanisms in ATP synthase deficient patient cells —
impairment of ATP provision and oxidative stress.
This work was supported by grants from Ministry of Health
(NS9759-4/2008) and Ministry of Education (1M6837805002, AV0Z
50110509) of the Czech Republic.
doi:10.1016/j.bbabio.2010.04.173
4P.12 POLG mutations lead to decreased mitochondrial DNA
repopulation rates after EtBr-induced depletion in fibroblasts
Susanne Schoeler, Miriam Baron, Wolfram S. Kunz
Division of Neurochemistry, Dept. Epileptology and Life&Brain Center,
University Bonn, Germany
E-mail: Susanne.Schoeler@gmx.net
Mutations in nuclear genes encoding proteins that are involved in
mitochondrial DNA (mtDNA) maintenance, e.g. POLG, TK2, are
associated with various neurodegenerative disorders [1]. All patho-
genic mutations in these nuclear genes lead to mtDNA depletion and
secondary mtDNA mutations, which cause dysfunction of the
oxidative phosphorylation and lead to disease phenotype. Until
now it is a major challenge to demonstrate the direct functional
consequences of those mutations. To address the issue, whether POLG
or TK2 mutations lead to impaired mtDNA maintenance, a kinetic
assay for mtDNA replication in primary human fibroblasts was
performed. Different fibroblast cell lines were depleted of their
mtDNA by treatment with ethidium bromide (EtBr) and the rates of
mtDNA repopulationwere determined. Here we demonstrate that the
rate of mtDNA depletion, induced by EtBr, showed no significant
difference between patients and controls. In contrast, the restoration
of mtDNA levels is significantly delayed in fibroblasts from patients
with POLG mutations, while TK2 mutations have no effect on mtDNA
repopulation rates. These findings provide the first in vivo evidence
that pathogenic POLG mutations directly influence the mtDNA
maintenance in human cells. Furthermore, these results are in line
with in vitro data showing reduced catalytic activity and processivity
for several pathogenic POLG alleles [2–5].
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Diabetes is a mitochondrial disease. Atherosclerotic coronary
artery disease (CAD) is the leading cause of mortality in diabetic
patients. Mitochondrial dysfunction and increased production of
reactive oxygen species (ROS) are associated with diabetes and CAD.
Elevated levels of glycated low density lipoproteins (glyLDL) and
oxidized LDL (oxLDL) were detected in patients with diabetes. Our
previous studies demonstrated that oxLDL and glyLDL increased the
generation of ROS and altered the activities of antioxidant enzymes in
vascular endothelial cells (EC). The present study examined the
effects of glyLDL and oxLDL on oxygen consumption in mitochondria
and the activities of key enzymes in mitochondrial electron transport
chain (ETC) in cultured porcine aortic EC. The results demonstrated
that glyLDL or oxLDL significantly impaired oxygen consumption in
Complex I, II/III and IV of mitochondrial ETC in EC compared to LDL or
vehicle control detected using oxygraphy. Incubation with glyLDL or
oxLDL significantly reduced mitochondrial membrane potential, the
levels of NAD+/NADH ratio, and the activities of mitochondrial ETC
enzymes (NADH–ubiquinone dehydrogenase, succinate cytochrome c
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